House Bills - 108th Congress

H.R. 2356—Prescription Drug Comparative Effectiveness Act of 2003

On June 5, 2003, Representative Thomas Allen (D-ME) introduced H.R. 2356, the Prescription Drug Comparative Effectiveness Act of 2003. The bill would require NIH, in coordination with AHRQ, to conduct research, including clinical research, to compare the effectiveness, cost, and when appropriate, safety of high-cost or high-use prescription drugs covered by federally-funded health programs. H.R. 2356 was referred to the House Committee on Energy and Commerce.